Literature DB >> 18215182

Diaphragm muscle strip preparation for evaluation of gene therapies in mdx mice.

John A Faulkner1, Rainer Ng, Carol S Davis, Sheng Li, Jeffrey S Chamberlain.   

Abstract

1. Duchenne muscular dystrophy (DMD), a severe muscle wasting disease of young boys with an incidence of one in every 3000, results from a mutation in the gene that encodes dystrophin. The absence of dystrophin expression in skeletal muscles and heart results in the degeneration of muscle fibres and, consequently, severe muscle weakness and wasting. The mdx mouse discovered in 1984, with some adjustments for differences, has proven to be an invaluable model for scientific investigations of dystrophy. 2. The development of the diaphagm strip preparation provided an ideal experimental model for investigations of skeletal muscle impairments in structure and function induced by interactions of disease- and age-related factors. Unlike the limb muscles of the mdx mouse, which show adaptive changes in structure and function, the diaphragm strip preparation reflects accurately the deterioration in muscle structure and function observed in boys with DMD. 3. The advent of sophisticated servo motors and force transducers interfaced with state-of-the-art software packages to drive complex experimental designs during the 1990s greatly enhanced the capability of the mdx mouse and the diaphragm strip preparation to evaluate more accurately the impact of the disease on the structure-function relationships throughout the life span of the mouse. 4. Finally, during the 1990s and through the early years of the 21st century, many promising, sophisticated genetic techniques have been designed to ameliorate the devastating impact of muscular dystrophy on the structure and function of skeletal muscles. During this period of rapid development of promising genetic therapies, the combination of the mdx mouse and the diaphragm strip preparation has provided an ideal model for the evaluation of the success, or failure, of these genetic techniques to improve dystrophic muscle structure, function or both. With the 2 year life span of the mdx mouse, the impact of age-related effects can be studied in this model.

Entities:  

Mesh:

Year:  2008        PMID: 18215182     DOI: 10.1111/j.1440-1681.2007.04865.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  14 in total

1.  A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection.

Authors:  Pascal Stuelsatz; Paul Keire; Ricardo Almuly; Zipora Yablonka-Reuveni
Journal:  J Histochem Cytochem       Date:  2012-06-21       Impact factor: 2.479

2.  Diaphragm muscle sarcopenia in aging mice.

Authors:  Sarah M Greising; Carlos B Mantilla; Britney A Gorman; Leonid G Ermilov; Gary C Sieck
Journal:  Exp Gerontol       Date:  2013-06-19       Impact factor: 4.032

3.  Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Justin M Percival; Nicholas P Whitehead; Marvin E Adams; Candace M Adamo; Joseph A Beavo; Stanley C Froehner
Journal:  J Pathol       Date:  2012-07-18       Impact factor: 7.996

4.  A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy.

Authors:  Kumaran Chandrasekharan; Jung Hae Yoon; Ying Xu; Sarah deVries; Marybeth Camboni; Paulus M L Janssen; Ajit Varki; Paul T Martin
Journal:  Sci Transl Med       Date:  2010-07-28       Impact factor: 17.956

5.  Loss of α-actinin-3 confers protection from eccentric contraction damage in fast-twitch EDL muscles from aged mdx dystrophic mice by reducing pathological fibre branching.

Authors:  Leonit Kiriaev; Peter J Houweling; Kathryn N North; Stewart I Head
Journal:  Hum Mol Genet       Date:  2022-05-04       Impact factor: 5.121

6.  Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.

Authors:  Nicholas P Whitehead; Kenneth L Bible; Min Jeong Kim; Guy L Odom; Marvin E Adams; Stanley C Froehner
Journal:  J Physiol       Date:  2016-10-13       Impact factor: 5.182

Review 7.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Authors:  David G Allen; Nicholas P Whitehead; Stanley C Froehner
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

8.  Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles.

Authors:  Niclas E Bengtsson; Hichem Tasfaout; Stephen D Hauschka; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2020-11-05       Impact factor: 11.454

9.  Muscle structure influences utrophin expression in mdx mice.

Authors:  Glen B Banks; Ariana C Combs; Guy L Odom; Robert J Bloch; Jeffrey S Chamberlain
Journal:  PLoS Genet       Date:  2014-06-12       Impact factor: 5.917

10.  Role of dystrophin in airway smooth muscle phenotype, contraction and lung function.

Authors:  Pawan Sharma; Sujata Basu; Richard W Mitchell; Gerald L Stelmack; Judy E Anderson; Andrew J Halayko
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.